Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

Latest Articles

  • You have access
    Evidence, limes, and cement
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine January 2010, 77 (1) 7; DOI: https://doi.org/10.3949/ccjm/77a.01001

    Sometimes, the results of clinical trials do not immediately affect what physicians do because the results do not jibe with experience.

  • You have access
    Index to volume 76
    Cleveland Clinic Journal of Medicine December 2009, 76 (12) 731-734;
  • You have access
    Advances in therapy for type 2 diabetes: GLP–1 receptor agonists and DPP–4 inhibitors
    Laurence Kennedy, MD and Jaime A. Davidson, MD
    Cleveland Clinic Journal of Medicine December 2009, 76 (12 suppl 5) S28-S38; DOI: https://doi.org/10.3949/ccjm.76.s5.05
  • You have access
    Patient and treatment perspectives: Revisiting the link between type 2 diabetes, weight gain, and cardiovascular risk
    Laurence Kennedy, MD and Anne L. Peters, MD, CDE
    Cleveland Clinic Journal of Medicine December 2009, 76 (12 suppl 5) S20-S27; DOI: https://doi.org/10.3949/ccjm.76.s5.04
  • You have access
    Role of the incretin pathway in the pathogenesis of type 2 diabetes mellitus
    Laurence Kennedy, MD and Jeffrey S. Freeman, DO
    Cleveland Clinic Journal of Medicine December 2009, 76 (12 suppl 5) S12-S19; DOI: https://doi.org/10.3949/ccjm.76.s5.03
  • You have access
    Current antihyperglycemic treatment strategies for patients with type 2 diabetes mellitus
    Laurence Kennedy, MD and Lawrence Blonde, MD
    Cleveland Clinic Journal of Medicine December 2009, 76 (12 suppl 5) S4-S11; DOI: https://doi.org/10.3949/ccjm.76.s5.02
  • You have access
    Incretin-based therapies for type 2 diabetes mellitus: New therapeutic mechanisms
    Laurence Kennedy, MD
    Cleveland Clinic Journal of Medicine December 2009, 76 (12 suppl 5) S2-S3; DOI: https://doi.org/10.3949/ccjm.76.s5.01
  • You have access
    Redefining treatment success in type 2 diabetes mellitus: Comprehensive targeting of core defects
    Laurence Kennedy, MD, William T. Cefalu, MD, Robert J. Richards, MD and Lydia Y. Melendez-Ramirez, MD
    Cleveland Clinic Journal of Medicine December 2009, 76 (12 suppl 5) S39-S47; DOI: https://doi.org/10.3949/ccjm.76.s5.06
  • You have access
    Fragility fractures in chronic kidney disease: An opinion-based approach
    Paul D. Miller, MD
    Cleveland Clinic Journal of Medicine December 2009, 76 (12) 715-723; DOI: https://doi.org/10.3949/ccjm.76a.08108

    When a patient with chronic kidney disease suffers a fragility fracture, a key question is whether the patient has osteoporosis or, instead, renal osteodystrophy. Bone densitometry does not help in this distinction.

  • You have access
    Prasugrel for acute coronary syndromes: Faster, more potent, but higher bleeding risk
    Lawrence D. Lazar, MD and A. Michael Lincoff, MD
    Cleveland Clinic Journal of Medicine December 2009, 76 (12) 707-714; DOI: https://doi.org/10.3949/ccjm.76a.09116

    Prasugrel (Effient) is faster and more consistent in its effects, but patients at high bleeding risk should still receive clopidogrel (Plavix).

Pages

  • Previous
  • Next
  • 1
  • …
  • 236
  • 237
  • 238
  • 239
  • 240
  • 241
  • 242
  • 243
  • 244
  • …
  • 798

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire